Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Biotechnology

Capricor Therapeutics

Linda Marbán

Jonathan Tayco

Yushi Feng

Joe Z.

Cecelia Smiley-Adams

Mark Awadalla

Aj Bergmann

Kristi A. H. Elliott

The executive team of Capricor Therapeutics has experience working in finance and accounting, as well as law. They also have entrepreneurial experience and education. This background gives them the skills and knowledge necessary to lead the company and make financial and legal decisions.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Capricor Therapeutics

Board of Directors

Leadership Team